MRIMed recalled 314 batteries for the SL-110 Mobile Exam Light on October 13, 2025. The batteries can overheat while charging, melting internal components and producing smoke. This recall affects devices distributed in the U.S. and several countries worldwide.
Due to battery component overheating while charging resulting in melting of internal components and causing smoke.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact MRIMed Inc. or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled product is the MRI LED Mobile Exam Light Battery REF SL-111, designed for use with the SL-110 Mobile Exam Light. The batteries were distributed worldwide, including in 15 U.S. states and countries such as Germany and Canada.
The batteries can overheat during charging, leading to melting of internal components and smoke emissions. This poses a significant risk of fire and injury.
As of now, no injuries or incidents have been reported in connection with this recall. The recall was initiated following safety concerns regarding the battery's performance under charging conditions.
Stop using the affected batteries immediately. Contact MRIMed Inc. or your healthcare provider for further instructions and follow the recall instructions provided.
For more information, contact MRIMed Inc. at [insert phone number] or visit their website. Further details can be found on the FDA's official recall page.
Get instant alerts for recalls that affect you. Free forever.
AvKARE recalled Amantadine HCl capsules on February 13, 2026, due to failed dissolution specifications. The recall affects the 100 mg capsules, which may not dissolve properly. Consumers should stop using this product and contact their healthcare provider immediately.
Slate Run Pharmaceuticals recalled Eptifibatide Injection on February 12, 2026. The recall affects all lots of the 75 mg/100 mL vial due to incorrect dosing information. Healthcare providers and consumers must stop using the product immediately.
LEO Pharma Inc. recalled 11,407 units of Adbry injection on February 10, 2026. The recall stems from a lack of assurance of sterility due to particulate matter identified as wool fiber. Consumers should stop using the product immediately and contact their healthcare provider for guidance.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Hitachi Ltd. recalled one unit of its Proton Beam Therapy System on February 6, 2026 due to a software anomaly. The issue may result in positional discrepancies during patient treatment. The recall affects distribution in Texas and Washington D.C.
Hitachi recalled its Proton Beam Therapy System on February 6, 2026, due to a software anomaly that may result in positional discrepancies. The recall affects one unit distributed in Texas and Washington D.C. Healthcare providers and patients must stop using the device immediately.
Fresenius Kabi Compounding recalled 1,057 bags of Acyclovir Sodium Injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers should cease use immediately and contact the manufacturer for guidance.
Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.